<DOC>
	<DOCNO>NCT00607048</DOCNO>
	<brief_summary>This dose-finding study ; therefore , hypothesis testing</brief_summary>
	<brief_title>Dose Finding Study Of CP-870,893 , An Immune System Stimulating Antibody , In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Patients metastatic solid tumor , carboplatin paclitaxel appropriate ; Patients &gt; 18 year age ; Good performance status ; Adequate bone marrow organ function Previous treatment compound target CD40 Current plan concurrent treatment anticancer agent ; Patients receive bone marrow transplant ; History autoimmune disorder History ( within previous year ) heart failure heart attack Cancerassociated coagulation disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>